Star Health Adjusts Valuation Amid Declining Profits and Market Scrutiny
Star Health & Allied Insurance Company has experienced a change in its valuation grade, reflecting a fair assessment within the large-cap insurance sector. Key financial metrics, including a PE ratio of 41.46 and a ROCE of 16.62%, indicate moderate profitability, despite recent challenges and a decline in profit after tax.
Star Health & Allied Insurance Company has recently undergone an adjustment in its evaluation, reflecting a shift in its valuation grade. The company, operating within the large-cap insurance sector, has seen its valuation change from a previously higher tier to a fair assessment. This adjustment is influenced by several key financial metrics.The price-to-earnings (PE) ratio stands at 41.46, while the price-to-book value is noted at 3.98. The enterprise value to EBITDA ratio is recorded at 31.56, indicating the company's valuation in relation to its earnings before interest, taxes, depreciation, and amortization. Additionally, the return on capital employed (ROCE) is at 16.62%, and the return on equity (ROE) is 9.59%, suggesting a moderate level of profitability relative to its equity base.
Despite facing challenges, including a significant decline in profit after tax for the latest quarter, Star Health maintains a strong long-term fundamental strength with a compound annual growth rate (CAGR) of 26.73% in operating profits. The stock's performance has been under scrutiny, particularly in comparison to broader market indices, highlighting its recent struggles.
For those interested in further insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
